{"DataElement":{"publicId":"5741173","version":"1","preferredName":"Treatment Cohort Study 10007 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10007 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_10007_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5741170","version":"1","preferredName":"10007 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"5741170v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"TAC2","valueDescription":"TAC2: Patients less than 18 years, Selumetinib (AZD6244 hydrogen sulfate): 25 mg/m2 PO BID","ValueMeaning":{"publicId":"5741171","version":"1","preferredName":"TAC2: Patients less than 18 years, Selumetinib (AZD6244 hydrogen sulfate): 25 mg/m2 PO BID","longName":"5741171","preferredDefinition":"TAC2: Patients less than 18 years, Selumetinib (AZD6244 hydrogen sulfate): 25 mg/m2 PO BID","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C827199-DFAC-1F9F-E053-F662850AC3FB","latestVersionIndicator":"Yes","beginDate":"2017-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-04-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C827199-DFC5-1F9F-E053-F662850AC3FB","beginDate":"2017-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-04-06","modifiedBy":"ONEDATA","dateModified":"2017-04-06","deletedIndicator":"No"},{"value":"TAC1","valueDescription":"TAC1: Patients greater than or equal to 18 years, Selumetinib (AZD6244 hydrogen sulfate): 50 mg PO BID; Dose may be escalated to 75 mg PO BID starting with cycle 2","ValueMeaning":{"publicId":"5741172","version":"1","preferredName":"TAC1: Patients greater than or equal to 18 years, Selumetinib (AZD6244 hydrogen sulfate): 50 mg PO BID; Dose may be escalated to 75 mg PO BID starting with cycle 2","longName":"5741172","preferredDefinition":"TAC1: Patients greater than or equal to 18 years, Selumetinib (AZD6244 hydrogen sulfate): 50 mg PO BID; Dose may be escalated to 75 mg PO BID starting with cycle 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C827199-DFCF-1F9F-E053-F662850AC3FB","latestVersionIndicator":"Yes","beginDate":"2017-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-04-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C827199-DFE8-1F9F-E053-F662850AC3FB","beginDate":"2017-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-04-06","modifiedBy":"ONEDATA","dateModified":"2017-04-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C827199-DF94-1F9F-E053-F662850AC3FB","latestVersionIndicator":"Yes","beginDate":"2017-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-04-06","modifiedBy":"TAYLORT","dateModified":"2017-04-06","changeDescription":"4/6/17 tt/ 10007.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Please select the cohort:","type":"Preferred Question Text","description":"Please select the cohort:","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C822BFB-8B88-25F3-E053-F662850AD460","latestVersionIndicator":"Yes","beginDate":"2017-04-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-04-06","modifiedBy":"TAYLORT","dateModified":"2017-04-06","changeDescription":"4/6/17 tt/10007.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}